Growth Metrics

Biogen (BIIB) Other Working Capital Changes (2016 - 2025)

Biogen has reported Other Working Capital Changes over the past 17 years, most recently at -$119.3 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$119.3 million for Q4 2025, down 217.29% from a year ago — trailing twelve months through Dec 2025 was $60.6 million (up 115.66% YoY), and the annual figure for FY2025 was $60.6 million, up 115.66%.
  • Other Working Capital Changes for Q4 2025 was -$119.3 million at Biogen, down from $104.4 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for BIIB hit a ceiling of $213.6 million in Q1 2022 and a floor of -$149.9 million in Q3 2022.
  • Median Other Working Capital Changes over the past 5 years was $16.2 million (2021), compared with a mean of $5.6 million.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 537.3% in 2021 and later tumbled 1445.36% in 2022.
  • Biogen's Other Working Capital Changes stood at -$88.8 million in 2021, then skyrocketed by 139.3% to $34.9 million in 2022, then crashed by 291.4% to -$66.8 million in 2023, then soared by 43.71% to -$37.6 million in 2024, then tumbled by 217.29% to -$119.3 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$119.3 million (Q4 2025), $104.4 million (Q3 2025), and $22.0 million (Q2 2025) per Business Quant data.